Search research articles
Contact Us
Filters
Showing results (81-90 of 1,024) with videos related to
Page
of 103
Sort By:
Gut
|
December 3, 2025
Nucleos(t)ide analogue therapy for EASL immune-tolerant phase hepatitis B
Chia-Ming Chu, Yun-Fan Liaw
Zhongguo Fei AI Za Zhi = Chinese Journal of Lung Cancer
|
June 24, 2017
[Prospect and Current Situation of Immune Checkpoint Inhibitors in First-line Treatment in Advanced Non-small Cell Lung Cancer Patients]
Haiyang Wang, Xiaoqing Yu, Yun Fan
Gastroenterology
|
October 16, 2007
Predictive factors for reactivation of hepatitis B following hepatitis B e antigen seroconversion in chronic hepatitis B
Chia-Ming Chu, Yun-Fan Liaw
Antiviral Therapy
|
April 14, 2010
Hepatitis B surface antigen seroclearance during chronic HBV infection
Chia-Ming Chu, Yun-Fan Liaw
Seminars in Liver Disease
|
June 28, 2021
Finite Antiviral Therapy in Chronic Hepatitis B Patients with Cirrhosis
Wen-Juei Jeng, Yun-Fan Liaw
International Journal of Cardiology
|
December 10, 2020
METTL14 mediated m6A modification to LncRNA ZFAS1/ RAB22A: A novel therapeutic target for atherosclerosis
Chengwu Gong, Yun Fan, Jichun Liu
International Journal of Molecular Sciences
|
February 15, 2022
Hepatitis B Flare in Hepatitis B e Antigen-Negative Patients: A Complicated Cascade of Innate and Adaptive Immune Responses
Ming-Ling Chang, Yun-Fan Liaw
The Kaohsiung Journal of Medical Sciences
|
March 9, 2022
Finite nucleos(t)ide analogue therapy in hepatitis B e antigen-negative chronic hepatitis B: From an "option" to an "active recommendation"
Yun-Fan Liaw, Rong-Nan Chien
Frontiers in Oncology
|
May 20, 2021
KRAS-Mutant Non-Small Cell Lung Cancer: An Emerging Promisingly Treatable Subgroup
Mingying Xie, Xiaoling Xu, Yun Fan
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America
|
November 5, 2011
Prevalence of and risk factors for hepatitis B viremia after spontaneous hepatitis B surface antigen seroclearance in hepatitis B carriers
Chia-Ming Chu, Yun-Fan Liaw
Page
of 103
Search research articles
Search
Showing results (81-90 of 1,024) with videos related to
Sort By:
Page
of 103
Gut
|
December 3, 2025
Nucleos(t)ide analogue therapy for EASL immune-tolerant phase hepatitis B
Chia-Ming Chu, Yun-Fan Liaw
Zhongguo Fei AI Za Zhi = Chinese Journal of Lung Cancer
|
June 24, 2017
[Prospect and Current Situation of Immune Checkpoint Inhibitors in First-line Treatment in Advanced Non-small Cell Lung Cancer Patients]
Haiyang Wang, Xiaoqing Yu, Yun Fan
Gastroenterology
|
October 16, 2007
Predictive factors for reactivation of hepatitis B following hepatitis B e antigen seroconversion in chronic hepatitis B
Chia-Ming Chu, Yun-Fan Liaw
Antiviral Therapy
|
April 14, 2010
Hepatitis B surface antigen seroclearance during chronic HBV infection
Chia-Ming Chu, Yun-Fan Liaw
Seminars in Liver Disease
|
June 28, 2021
Finite Antiviral Therapy in Chronic Hepatitis B Patients with Cirrhosis
Wen-Juei Jeng, Yun-Fan Liaw
International Journal of Cardiology
|
December 10, 2020
METTL14 mediated m6A modification to LncRNA ZFAS1/ RAB22A: A novel therapeutic target for atherosclerosis
Chengwu Gong, Yun Fan, Jichun Liu
International Journal of Molecular Sciences
|
February 15, 2022
Hepatitis B Flare in Hepatitis B e Antigen-Negative Patients: A Complicated Cascade of Innate and Adaptive Immune Responses
Ming-Ling Chang, Yun-Fan Liaw
The Kaohsiung Journal of Medical Sciences
|
March 9, 2022
Finite nucleos(t)ide analogue therapy in hepatitis B e antigen-negative chronic hepatitis B: From an "option" to an "active recommendation"
Yun-Fan Liaw, Rong-Nan Chien
Frontiers in Oncology
|
May 20, 2021
KRAS-Mutant Non-Small Cell Lung Cancer: An Emerging Promisingly Treatable Subgroup
Mingying Xie, Xiaoling Xu, Yun Fan
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America
|
November 5, 2011
Prevalence of and risk factors for hepatitis B viremia after spontaneous hepatitis B surface antigen seroclearance in hepatitis B carriers
Chia-Ming Chu, Yun-Fan Liaw
Page
of 103